Showing 161 - 180 results of 101,585 for search '(( 5 ((((mg decrease) OR (mean decrease))) OR (a decrease)) ) OR ( 16 w decrease ))', query time: 1.44s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164

    Resveratrol decreased intracellular levels of R5P. by Mohd Askandar Iqbal (324124)

    Published 2013
    “…<p>R5P is a pentose phosphate pathway intermediate, an important marker for anabolism (nucleotide biosynthesis). …”
  5. 165

    Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

    Published 2011
    “…<p>(A–B) Melanophores within the trunk region above the yolk sac extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n = 15 embryos and SEM is shown by bar. p values obtained from Student's t-test. ** denotes p<0.01. …”
  6. 166
  7. 167
  8. 168

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”
  9. 169
  10. 170
  11. 171

    DHT increases whereas orchidectomy decreases the weight and cross sectional area of hindlimb muscles. by Young-Eun Yoo (323357)

    Published 2013
    “…<b>A:</b> In WT mice, DHT increased the GN weight by 7% (212.4±8.8 mg), whereas orchidectomy decreased it by 14% (171.4±9.0 mg) compared with control WT mice (198.4±5.5 mg). …”
  12. 172

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…White line indicates the presence of tumor. <b>Panel b:</b> A boxplot of tumor burden in MDA-MB-231 tumor-bearing mice treated with either 13C4 (10 mg/kg) or 1D11(10 mg/kg) for 4 weeks, starting 1 day after tumor cell injection (N = at least 7) showing decrease in tumor burden. …”
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180